OpenAlex
PricingAboutJobs
Log inGet started
Work

MEK inhibitors in oncology: a patent review (2015-Present)

HTML

Year: 2017
Type: review
Source: Expert Opinion on Therapeutic Patents
DOI: 10.1080/13543776.2017.1339688
Authors: Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti
Institutions: Rashtrasant Tukadoji Maharaj Nagpur University, Guru Ghasidas Vishwavidyalaya
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: MEK inhibitors, RAS/MAPK pathway, PI3K/AKT/mTOR pathway, metastatic melanoma, BRAF mutation, KRAS mutation, multikinase inhibitor, acquired drug resistance, relapsed/refractory multiple myeloma, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, precision oncology, pharmaceutical patents
SDG: Good health and well-being

Open Access status: closed

Funder: University Grants Commission
OpenAlex ID: W2622197960
FWCI: 0.469
Cites: 55
Cited by: 48
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security